Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Invested Capital (2016 - 2025)

Historic Invested Capital for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $454.6 million.

  • Orthopediatrics' Invested Capital rose 152.8% to $454.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $454.6 million, marking a year-over-year increase of 152.8%. This contributed to the annual value of $432.0 million for FY2024, which is 1132.76% up from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Invested Capital is $454.6 million, which was up 152.8% from $458.2 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Invested Capital peaked at $458.2 million during Q2 2025, and registered a low of $216.1 million during Q1 2022.
  • In the last 5 years, Orthopediatrics' Invested Capital had a median value of $381.1 million in 2023 and averaged $349.1 million.
  • As far as peak fluctuations go, Orthopediatrics' Invested Capital crashed by 861.22% in 2021, and later soared by 7311.61% in 2023.
  • Over the past 5 years, Orthopediatrics' Invested Capital (Quarter) stood at $226.4 million in 2021, then surged by 67.64% to $379.6 million in 2022, then rose by 2.25% to $388.1 million in 2023, then rose by 11.33% to $432.0 million in 2024, then increased by 5.22% to $454.6 million in 2025.
  • Its Invested Capital was $454.6 million in Q3 2025, compared to $458.2 million in Q2 2025 and $424.5 million in Q1 2025.